1. Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer Type;Wilcock,1997
2. Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease;Wilkinson;International Journal of Geriatric Psychiatry,2001
3. Kristensen M Richardson A Van Osselaer N Vangeneugden T Morrison S Fleet D Lilienfeld S Truyen L Parys W A Europan multicentre placebo-controlled trial to determine the safety and efficacy of galantamine hydrobromide 40mg/d (32mg/d GAL bas, tid dose regimen) in patients diagnosed with Alzheimer-type dementia (GAL 95-05) Janssen Research Foundation 1997
4. GALANTAMINE ALLEVIATES CAREGIVER BURDEN IN ALZHEIMER'S DISEASE: A 6-MONTH PLACEBO-CONTROLLED STUDY;Wilcock,2000
5. Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449));Wilcock;BR-MED-J: British-Medical-Journal,2001